Some have relabeled it as Pentadecapeptide Aringate or PDA (switching the acetate to an arginate) and they are prescribing it for subcutaneous administration this way, while the confusion about its position has resulted in a vivid oral capsule market for BPC in what appears to generally be a gray space https://archbishopc384atn1.theisblog.com/profile